The Jiva Integrated Medication Management platform also maximizes government program compliance and scores by being CMS compliant in the Medicare Part D solution, and encompasses embedded intelligence and workflow to help healthcare organizations proactively meet medication-related Star measures.
ZeOmega is offering healthcare providers and organizations a free ROI assessment to determine their potential overall medical savings by deploying Jiva Integrated Medication Management. Please fill out the online form located at http://www.zeomega.com/zeomega-resources/imm-roi/ for an assessment based on your organization’s unique data.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About ZeOmega
ZeOmega’s powerful population health management platform delivers high-value, strategic solutions enabling payers and care-delivery organizations to improve individual health and provider performance. With deep domain expertise and a comprehensive understanding of complex population health challenges, ZeOmega serves as a “true-north” partner for clients—offering flexible deployment and delivery models that leverage an innovative platform designed to integrate workflow, analytics, content and communication capabilities. By consistently meeting customer expectations and project benchmarks, ZeOmega has earned a sterling reputation in the industry for responsiveness and reliability. For more information, visit www.zeomega.com or call 214-618-9880. Follow ZeOmega on Twitter, LinkedIn or Facebook.
# # #
Media Contact:
Tony Katsulos
Jetstream PR for ZeOmega
katsulos@jetstreampr.com
972.788.9456, x301 – Office
972.741.8545 – Mobile
Trademark Information: ZeOmega and Jiva are registered trademarks or trademarks of ZeOmega Inc. or its subsidiaries in the United States and other countries. Other marks or brands may be claimed as the property of others.
Back to HCB News
